Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vickers Vantage Corp. I | 250,000 | reported | 17 Jan 2023 | tx 1+250,000 |
| Jazz Pharmaceuticals plc | 6,933 | reported | 08 Aug 2025 | tx 3+7,238−1,805 |
| GILEAD SCIENCES, INC. | 6,340 | reported | 08 May 2019 | tx 6+207,055−3,500 |
| ANAPTYSBIO, INC | 3,900 | reported | 06 Jan 2023 | tx 7+53,968 |
| FS Development Corp. II | 0 | reported | 31 Aug 2023 | tx 7+150,000−220,390 |
| Y-mAbs Therapeutics, Inc. | 0 | reported | 16 Sept 2025 | tx 17+156,850−146,850 |
| ACCELERON PHARMA INC | 0 | reported | 19 Nov 2021 | tx 6+10,754−10,754 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Sept 2025 | TENDER | Y-mAbs Therapeutics, Inc. | 5,825 | 8.60 USD | |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 25,080 | — | |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 27,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 11,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 33,450 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 13,950 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 14,545 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 16,000 | — | deriv |
| 07 Aug 2025 | GRANT_AWARD | Jazz Pharmaceuticals plc | 3,507 | 0.00 USD | |
| 08 Aug 2025 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 1,805 | 111.25 USD | |
| 30 Jun 2025 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 25,080 | 0.00 USD | |
| 30 Jun 2025 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 33,450 | 0.00 USD | deriv |
| 02 Aug 2024 | GRANT_AWARD | Jazz Pharmaceuticals plc | 3,731 | 0.00 USD | |
| 11 Jun 2024 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 3,495 | 0.00 USD | |
| 11 Jun 2024 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 14,545 | 0.00 USD | deriv |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 70,390 | — | deriv |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 37,500 | — | deriv |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 75,000 | — | deriv |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 37,500 | — | deriv |
| 08 Jun 2023 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 2,330 | 0.00 USD | |
| 08 Jun 2023 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 13,950 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | FS Development Corp. II | 37,500 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Vickers Vantage Corp. I | 250,000 | 0.00 USD | deriv |
| 06 Jan 2023 | GRANT_AWARD | ANAPTYSBIO, INC | 10,600 | 0.00 USD | deriv |
| 06 Jan 2023 | GRANT_AWARD | ANAPTYSBIO, INC | 3,900 | 0.00 USD | deriv |